Pancreatic cancer: Pancreatic tumour formation and recurrence after radiotherapy are blocked by targeting CD44

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 2, 2014, Pages 73-

  Wood, Natalie J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMALS; ANTIBODIES; ANTIGENS, CD44; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

HERMES ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY H4C4; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

CANCER RADIOTHERAPY; CANCER STEM CELL; HUMAN; NONHUMAN; NOTE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; TUMOR RECURRENCE; TUMOR XENOGRAFT;

EID: 84893794563     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.1     Document Type: Note

References (1)

1. Li, L. et al. Antibody against CD44s inhibits pancreatic tumor initiation and post-radiation recurrence in mice. Gastroenterology doi:10.1053/j.gastro. 2013.12.035